Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
12.9%
% of XLV's 62 holdings also in IHE
21.6%
% of IHE's 38 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 19.2% | 11.3% |
|
JOHNSON & JOHNSON | 7.1% | 22.2% | 7.1% |
|
MERCK & CO. INC. | 4.7% | 4.0% | 4.0% |
|
PFIZER INC | 2.7% | 4.0% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 5.5% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 10.5% |
|
ABBVIE INC | 5.6% |
|
ABBOTT LABORATORIES | 3.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
INTUITIVE SURGICAL INC | 3.6% |
|
AMGEN INC | 2.9% |
|
DANAHER CORP | 2.8% |
|
STRYKER CORP | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.3% |
XLV Underweight Relative to IHE
|
JOHNSON & JOHNSON | -15.0% |
|
ELI LILLY & CO | -7.9% |
|
VIATRIS, INC. | -5.1% |
|
CATALENT INC | -4.2% |
|
ROYALTY PHARMA PLC CLASS A | -4.1% |
|
INTRA-CELLULAR THERAPIES INC | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.3% |
 |
JAZZ PHARMACEUTICALS PLC | -3.1% |
|
ELANCO ANIMAL HEALTH, INC. | -2.9% |
|
ZOETIS INC | -2.9% |